Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT2017060610181N11
IRCT2017060610181N11
Completed
Phase 1

Effect of Chlorella supplementation on systematic symptoms and serum levels of prostaglandins, inflammatory and oxidative markers in women with primary dysmenorrhea

Vice chancellor for research of Ahvaz University of Medical sciences0 sites44 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research of Ahvaz University of Medical sciences
Enrollment
44
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research of Ahvaz University of Medical sciences

Eligibility Criteria

Inclusion Criteria

  • •having regular menstrual periods, moderate or severe dysmenorrheal and being single
  • •Exclusion criteria: pain throughout the menstrual cycle, sensitivity to non\-steroidal anti\-inflammatory drugs, use of any antioxidant supplements in the past three months, taking oral contraceptives, reproductive disorders and a history of any abdominal or pelvic surgery

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Effect of chlorella intake on the condition of long-distance runners.Healthy volunteer
JPRN-UMIN000050804Doshisha University20
Completed
Not Applicable
Effect of chlorella consumption with egg loading on cholesterol levels in normocholesterolemic adultsNot Applicable
KCT0000258Ewha Womans University34
Completed
Not Applicable
Effect of chlorella consumption on cholesterol levels in mildly hypercholesterolemic adultsNot Applicable
KCT0000259Ewha Womans University68
Completed
Not Applicable
A study of the efficacy of a combination of chlorambucil and lomustine and etoposide (CLE 56) for absolute refractory prostate cancerProstate cancerCancer
ISRCTN50615178Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)40
Completed
Not Applicable
The Effect of Chlorella Vulgaris Supplementation on Metabolic, Blood Pressure and Antropometric Indices on Non-alcoholic fatty liver disease (NAFLD) patientson-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified
IRCT2012110911220N1Tabriz University of Medical Sciences50